DUBLIN--(BUSINESS WIRE)--The "Europe Actinic Keratosis Market and Competitive Landscape - 2018" report has been added to ResearchAndMarkets.com's offering. Europe Actinic Keratosis Market and ...

Credit: Almirall. The expanded approval was based on data from a phase 3 safety study which evaluated tirbanibulin in more than 100 adult patients with actinic keratosis. Findings showed the safety ...

DUBLIN, December 03, 2021--(BUSINESS WIRE)--The "Actinic Keratosis - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. This report delivers an in-depth ...

PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps that are ...

Actinic keratosis is a precancerous growth on the skin that forms due to long-term exposure to UV light. It is also known as solar keratosis. Actinic keratosis growths often appear in groups. The ...

Please provide your email address to receive an email when new articles are posted on . Patients and clinicians agreed overall skin appearance and texture were improved with tirbanibulin treatment.

Almirall S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, presented today the results of a survey revealing that 85% of respondents are unaware of the existence of ...

What's new concerning our understanding of actinic keratosis? Find out in this easy-to-navigate collection of recent MEDLINE abstracts compiled by the editors at Medscape Dermatology. Imiquimod 5% ...

What is actinic keratosis? An actinic keratosis is a precancerous skin lesion. These lesions often appear as rough spots on the skin and are caused by sun exposure or indoor tanning. Untreated, they ...

Actinic keratosis is a common skin disease that may progress to invasive squamous cell carcinoma. A recent study revealed that the way actinic keratosis is framed significantly influences patients’ ...

New York, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Actinic Keratosis Treatment Market Size, Share & Industry Trends Analysis Report By Drug Class, ...

Leverkusen, 06 May 2015 - Biofrontera AG (AIM/FSE: B8F), the biopharmaceutical company focussing on sun induced skin cancer, has prepared a scientific publication about the results of the multi-centre ...